When compared to its role in other malignancies such as melanoma and breast cancer, where MFSD12 primarily drives tumorigenesis through metabolic reprogramming and proliferation, our study unveils a distinctive facet of MFSD12 in LIHC. This evidence concerns the gene MFSD12 and breast cancer.